Award
NIH Reporter #5K22CA282019-03
Boosting IL-12-induced anti-glioblastoma activity via immunotherapeutic extracellular vesicles.
Recipient
Massachusetts General Hospital, Boston, MA, United States
Award Amount
$160,561.00
Ceiling
$160,561.00
Awarded
December 15, 2025
Identifier
5K22CA282019-03
Award for research on enhancing anti-glioblastoma activity using immunotherapeutic extracellular vesicles, funded for fiscal year 2026.
Description
This project focuses on developing immunotherapeutic extracellular vesicles to enhance anti-glioblastoma activity, with a detailed research plan including technology development, resistance mechanism exploration, and immune cell crosstalk analysis.